NCT00591630
- Conditions
- Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
1,618 public trials
340 recruiting studies
Lymphoma, B-Cell trial results
NCT00004031
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Oregon Health & Science University Portland, Oregon, United States
- Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
- Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
Completed
CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)
NCT03289455
- Conditions
- B Acute Lymphoblastic Leukemia, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +22 more
- Locations
-
- Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom
- University College London Hospitals NHS Foundation Trust London, United Kingdom
- Royal Manchester Children's Hospital Manchester, United Kingdom
NCT04726995
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
NCT01713582
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +25 more
- Locations
-
Not specified
NCT01474681
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +51 more
- Locations
-
- Novartis Investigative Site Minneapolis, Minnesota, United States
Completed
A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma
NCT00002348
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +23 more
- Locations
-
- ILEX Oncology Inc San Antonio, Texas, United States
NCT01854606
- Conditions
- CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Washington University School of Medicine Dept of Oncology. St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center Onc. Dept. New York, United States
- Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States
- Novartis Investigative Site Rouen, France
NCT04160442
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
NCT00612716
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States